Cannabis Rescheduling Does Not Lift Federal Firearm Purchase Ban
DEA's move to Schedule III leaves 18 USC §922(g)(3) intact, barring unlawful users from gun ownership.

A soldier holding an assault rifle, wearing tactical gear in a dark environment.
Rescheduling Changes Tax Treatment, Not Criminal Firearm Prohibition
Cannabis rescheduling to Schedule III alters federal tax obligations under IRC §280E but doesn't modify the Gun Control Act's definition of prohibited persons. On a strict reading of 18 USC §922(g)(3), the statute bars any individual who's "an unlawful user of or addicted to any controlled substance (as defined in section 102 of the Controlled Substances Act)." Cannabis remains a controlled substance under the CSA. Schedule III, not Schedule I—but still controlled. Users who violate state or federal law remain disqualified.
DEA published the rescheduling final rule in May 2026. It moved cannabis and its derivatives to Schedule III effective immediately. That change removes the IRC §280E deduction prohibition for state-licensed operators. Title 18 of the United States Code? Untouched.
ATF Form 4473 Question 21.e Remains Enforceable
Bureau of Alcohol, Tobacco, Firearms and Explosives Form 4473, the federal firearm transaction record, continues to ask whether the transferee is "an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance." A "yes" answer disqualifies the applicant. A "no" answer by a cannabis user constitutes a false statement under 18 USC §922(a)(6), a felony punishable by up to ten years' imprisonment.
ATF hasn't issued revised guidance following rescheduling. The agency's September 2011 open letter to federal firearms licensees—which clarified that state medical-cannabis cards don't override federal prohibitions—remains in effect. That letter cited the Schedule I status of cannabis, but the operative statute, §922(g)(3), applies to all controlled substances without regard to schedule.
State-Licensed Use Still Constitutes Unlawful Use Under Federal Law
Possession and distribution of cannabis remain federal crimes under 21 USC §841 and §844, even after rescheduling to Schedule III. The CSA doesn't authorize state-licensed cannabis activity. Any cannabis use—medical or adult-use—qualifies as "unlawful" for purposes of the firearm-purchase prohibition. Why? It violates federal statute.
Rescheduling changes the regulatory framework for research and taxation, but it doesn't create a federal exemption for state-authorized cannabis programs.
For complete background on the intersection of cannabis policy and Second Amendment jurisprudence, see the CannIntel topic hub on Cannabis Rescheduling and Firearm Rights.
What Operators and Consumers Should Monitor
Congressional action remains the only route to reconcile state cannabis programs with federal firearm law. The SAFE Banking Act and its successors haven't addressed §922(g)(3). No pending bill in the 119th Congress proposes an amendment.
Operators advising employees and patients should note that rescheduling doesn't change compliance obligations under the Gun Control Act. Watch for DOJ or ATF guidance clarifying enforcement priorities in Schedule III jurisdictions. That's the next signal.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Lawmakers Push IRS for Cannabis Tax Guidance After Rescheduling
Congressional members are calling on the IRS to issue immediate tax guidance for cannabis operators following the DEA's rescheduling decision.

ATF Revises Gun Form 4473, Opening Path for Medical Cannabis Patients
New ATF guidance removes blanket marijuana disqualification from federal firearms background check form.

Louisiana Joins Multi-State Lawsuit to Block DEA Marijuana Rescheduling
Attorney General Liz Murrill adds Louisiana to coalition challenging federal reclassification from Schedule I to Schedule III.
More from the newsroom

Foley Hoag Outlines Nasdaq, NYSE Listing Path Post-Schedule III Move
Law firm's guidance details compliance steps for cannabis operators seeking U.S. exchange listings after rescheduling.

Multimillion-Dollar Queenbury Cannabis Facility Breaks Ground
A major cultivation and processing project in upstate New York moves forward after years of regulatory delays.

Curaleaf Loses Challenge to New Jersey Labor-Peace Mandate
Federal court upholds state requirement forcing cannabis operators to sign neutrality pacts with unions.